Radiopharmaceutical

Global Radiopharmaceutical Market is valued at USD 4050.3 Million in 2018 and expected to reach USD 6171.1 Million by 2025 with the CAGR of 6.20% over the forecast period. Growing preference of disease targeted cancer therapy, increasing patient awareness levels demanding accurate diagnosis and expanding applications of molecular imaging are some of the drivers of the global radiopharmaceuticals market.
Scope of Radiopharmaceutical Market Report:
Radiopharmaceuticals are those radioisotopes that are primarily used for diagnosis and therapeutic purposes. Radioisotopes can be used for diagnosis and treatment of various chronic diseases. Radioisotopes play a very crucial part in the medical diagnostic procedures. In combination with imaging devices which record the gamma rays emitted from inside, healthcare professionals can study the dynamic processes take place in various parts of the body. Radiopharmaceuticals, also known as nuclear medicines are used in applications such as lymphoma and bone metastasis. F-18, Tc-99, Ga-67, and I-123 are some of the nuclear medicines used in diagnostic procedures while I-131, Ir-192, Y-90 and Ra-223 are used in therapeutics procedures. Nuclear medicine imaging procedures are non-invasive and can be used for the treatment of several diseases, such as cancers, cardiovascular diseases and neurological disorders.

Global radiopharmaceutical market report is segmented on the basis of type, modality, application, procedures, end-users and by regional & country level. Based on type, global radiopharmaceutical market is classified as diagnostic and therapeutic. Based upon modality, global radiopharmaceutical market is classified into SPECT, PET, Alpha-emitters, Beta-emitters, and Brachytherapy. Based upon application, global radiopharmaceutical market is classified as oncology, cardiology, neurology, thyroid, and others. Based upon procedure, global radiopharmaceutical market is classified as oncology, cardiovascular, central nervous system, endocrine, skeletal, gastrointestinal, genito-urinary, pulmonary, PET & PET-CT, therapeutic, and others. Based upon end-user, global radiopharmaceutical market is classified ashospitals and diagnostic centers and research institutes.

The regions covered in this Global Radiopharmaceutical Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of radiopharmaceutical is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. 

Key Players for Global Radiopharmaceutical Market Report- Global radiopharmaceutical market report covers prominent players likeGE Healthcare, Bayer Healthcare, Cardinal Health Inc., Eczacibasi-Monrol Nuclear Products, Bracco Imaging S.p.A, Nordion Inc., Lantheus Medical Imaging Inc., Advanced Accelerator Applications S.A, Mallinckrodt plc, IBA Molecular Imaging and others.

Global Radiopharmaceutical Market Dynamics– The major factor driving the growth of the market is the rising prevalence of cardiovascular diseases worldwide. According to the estimates of the World Health Organization (WHO), in 2016, 17.9 million people died from CVDs. The conventional chemotherapy methods are being replaced by more convenient therapeutic radiopharmaceuticals for oncology and cancer treatment, which opens up new avenues in the radiopharmaceuticals market. Moreover, it not only benefits the physicians during diagnosis, but also works as a convenient and safer alternative for patients as compared to X-Rays and other external radiation imaging devices. However, stringent regulatory approvals, high cost of devices using radioisotopes, short half-life of radiopharmaceuticals and availability of conventional diagnostics procedures are some of the factors restraining the growth of the radiopharmaceuticals market.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Radiopharmaceutical Market. 

Key Benefits for Radiopharmaceutical Market Reports 
• Global market report covers in-depth historical and forecast analysis.
• Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global market report helps to identify opportunities in market place.
• Global market report covers extensive analysis of emerging trends and competitive landscape.

Global Radiopharmaceutical Market Segmentation:–
By Type:
•	Diagnostic
•	Therapeutic

By Modality:
•	SPECT
•	PET
•	Alpha-emitters
•	Beta-emitters
•	Brachytherapy

By Application:
•	Oncology
•	Cardiology
•	Neurology
•	Thyroid 
•	Others

By Procedures:
•	Oncology 
•	Cardiovascular 
•	Central Nervous System 
•	Endocrine 
•	Skeletal 
•	Gastrointestinal 
•	Genito-urinary 
•	Pulmonary 
•	PET & PET-CT 
•	Therapeutic 
•	Others

By End-User:
•	Hospitals and Diagnostic Centers
•	Research institutes

By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o UK
o France
o Germany
o Russia
o Rest of Europe
• Asia-Pacific
o China
o South Korea
o India
o Japan
o Rest of Asia-Pacific
• LAMEA
o Latin America
o Middle East
o Africa

Global Radiopharmaceutical Market Regional Analysis – North America dominates the radiopharmaceutical market due to presence of huge patient population suffering from various chronic diseases like cancer, coronary disorders, changing lifestyle and increasing research & development for effective and therapies with no side effects in this region. According to the National Cancer Institute, in 2016, 1.6 million new cases of cancer were diagnosed in the United States. Europe is the second largest market of radiopharmaceutical due to growing investment in research and presence of huge patient pool. According to the European Cardiovascular Disease Statistics 2017 report, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe.

Asia Pacific is the fastest growing market owing to the huge population base, increasing prevalence of chronic diseases, rapidly developing economies and increasing investments in healthcare. Moreover, growing awareness among individuals and rising diagnostic rates are also supplementing the demand for SPECT and PET devices in this region.

Radiopharmaceutical Market Key Players:
• GE Healthcare
• Bayer Healthcare
• Cardinal Health Inc.
• Eczacibasi-Monrol Nuclear Products
• Bracco Imaging S.p.A
• Nordion Inc.
• Lantheus Medical Imaging Inc.
• Advanced Accelerator Applications S.A
• Mallinckrodt plc,
• IBA Molecular Imaging
• Others

This comprehensive report will provide:

• Enhance your strategic decision making
• Assist with your research, presentations and business plans
• Show which emerging market opportunities to focus on
• Increase your industry knowledge
• Keep you up-to-date with crucial market developments
• Allow you to develop informed growth strategies
• Build your technical insight
• Illustrate trends to exploit
• Strengthen your analysis of competitors
• Provide risk analysis, helping you avoid the pitfalls other companies could make
• Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
• How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
• Which region has more opportunities?

Interested in this report?

Get your sample now!

Download Sample